(Q46470885)

22 December 2017

review article

1 reference

title

Implications of circadian clocks for the rhythmic delivery of cancer therapeutics (English)

1 reference

22 December 2017

0 references

4

Albert Goldbeter

1 reference

22 December 2017

Jean Clairambault

series ordinal

3

object named as

Jean Clairambault

1 reference

22 December 2017

author name string

Francis Lévi

series ordinal

1

1 reference

22 December 2017

Atilla Altinok

series ordinal

2

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

22 December 2017

Philosophical Transactions of the Royal Society A

published in

1 reference

22 December 2017

volume

366

1 reference

22 December 2017

issue

1880

1 reference

22 December 2017

page(s)

3575-3598

1 reference

22 December 2017

A cell cycle automaton model for probing circadian patterns of anticancer drug delivery

cites work

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

An age-and-cyclin-structured cell population model for healthy and tumoral tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Rhythms in human gastrointestinal mucosa and skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Mammalian cell cycles need two random transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Transition probability cell cycle model. Part I--Balanced growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Tumor suppression and circadian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Time-patterned drug administration: insights from a modeling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Tumor-based rhythms of anticancer efficacy in experimental models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Common pathways in circadian and cell cycle clocks: light-dependent activation of Fos/AP-1 in zebrafish controls CRY-1a and WEE-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Circadian chronotherapy for human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Oxaliplatin: pharmacokinetics and chronopharmacological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Implications of circadian clocks for the rhythmic delivery of cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Mammalian circadian signaling networks and therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Circadian variation in O6-alkylguanine-DNA alkyltransferase activity in circulating blood mononuclear cells of healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Control mechanism of the circadian clock for timing of cell division in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylases and dihydrouracil dehydrogenase in mouse liver. Possible relevance to chemotherapy with 5-fluoropyrimidines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Phase resetting of the mammalian circadian clock by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Rhythms in human bone marrow and blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Chronobiology, drug delivery, and chronotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Daily coordination of cancer growth and circadian clock gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

Circadian rhythm in dihydropyrimidine dehydrogenase activity and reduced glutathione content in peripheral blood of nasopharyngeal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTA.2008.0114

21 January 2018

Identifiers

DOI

10.1098/RSTA.2008.0114

1 reference

22 December 2017

1 reference

22 December 2017